Yüklüyor......
Circulating biomarkers to monitor cancer progression and treatment
Tumor heterogeneity is a major challenge and the root cause of resistance to treatment. Still, the standard diagnostic approach relies on the analysis of a single tumor sample from a local or metastatic site that is obtained at a given time point. Due to intratumoral heterogeneity and selection of s...
Kaydedildi:
| Yayımlandı: | Comput Struct Biotechnol J |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Research Network of Computational and Structural Biotechnology
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4913179/ https://ncbi.nlm.nih.gov/pubmed/27358717 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.csbj.2016.05.004 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|